Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-06-17 5:00 pm Unchanged | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 14,868,329 22.300% | 0 (Unchanged) | View |
| 2022-06-03 3:59 pm Sale | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 14,868,329 22.300% | -13,051,676 (-46.75%) | View |
| 2021-11-02 4:02 pm Sale | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 27,920,005 48.190% | -869,188 (-3.02%) | View |
| 2021-06-03 5:30 pm Purchase | 13D | NRX Pharmaceuticals Inc. NRXP | Javitt Jonathan C | 28,789,193 60.660% | 28,789,193 (New Position) | View |